Bupropion HCL ER
DLA Troop Support · DLA TROOP SUPPORT
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation SPE2D2-23-D-0002 in this department, oldest first.
- Sep 14, 2026 · this noticeAward NoticeRADHA PHARMACEUTICALS INC · $23.3M
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Note the winner and the end of the period of performance for the recompete.
- Follow the agency to see the next notice for this work.
What the notice says
Modification P00010 SPE2D223D0002 is issued to invoke option year 4 for Bupropion HCL ER National Contract. Modification P00009 SPE2D223D0002 is issued to incorporate clause 52.222-90, Addressing DEI Discrimination by Federal Contractors (DEVIATION 2026-O0040, REVISION 1) (APR 2026). Modification P00008 SPE2D223D0002 is issued to invoke option year 3 for Bupropion HCL ER National Contract. Modification P00007 SPE2D223D0002 is issued in accordance with DoD Class Deviation 2025-O0003 and Class Deviation 2025-O0004 into subject solicitation. Modification P00006 SPE2D223D0002 is issued to invoke o… (show all)
ption year 2 for Bupropion HCL ER National Contract. Modification P00005 SPE2D223D0002 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation. NATIONAL CONTRACT SPE2D2-23-D-0002 BUPROPION HCL ER
Who won similar work
15 award notices on SAM.gov in the last 24 months. Matched by: Same office (DLA TROOP SUPPORT), same product/service code (PSC) 6505 and NAICS 325412.
Single-winner award sizes (15): middle half $3.7M to $15.1M, median $10.3M; range $1.8M to $133.2M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| Golden State Medical Supply, Inc. | 8 | $202.2M | Oct 14, 2026 |
| AVKARE LLC | 2 | $13.7M | Sep 1, 2026 |
| Exelan Pharmaceuticals Inc. | 1 | $24.1M | Jun 13, 2025 |
| Bayer HealthCare Pharmaceuticals Inc | 1 | $10.3M | Jun 3, 2026 |
| PURACAP LABORATORIES LLC | 1 | $6.4M | Jun 9, 2026 |
| SpecGx, LLC | 1 | $5.9M | Sep 9, 2026 |
| PADAGIS SOURCING SOLUTIONS LLC | 1 | $3.2M | Jul 23, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- Oct 14, 2026Golden State Medical Supply, Inc.$15.3MPravastatin Solicitation
- Oct 7, 2026GOLDEN STATE MEDICAL SUPPLY INC$4.3MQuetiapine Fumarate XR Tablets
- Sep 24, 2026GOLDEN STATE MEDICAL SUPPLY INC$17.6MOlopatadine HCL 0.1% Ophthalmic Solution
- Sep 9, 2026SpecGx, LLC$5.9MMethylphenidate HCL IR
- Sep 3, 2026GOLDEN STATE MEDICAL SUPPLY, INC.$2.4MSolifenacin Award
- Sep 1, 2026AVKARE LLC$11.9MAnastrozole - Award
- Jul 23, 2026PADAGIS SOURCING SOLUTIONS LLC$3.2MClindamycin Phosphate - Benzoyl Peroxide Gel
- Jul 21, 2026GOLDEN STATE MEDICAL SUPPLY INC$12.1MTolterodine Tartrate ER 24HR Capsules
- Jul 14, 2026GOLDEN STATE MEDICAL SUPPLY, INC.$133.2MDuloxetine HCL DR Capsules
- Jul 1, 2026GOLDEN STATE MEDICAL SUPPLY INC$14.9MSumatriptan Succinate Tablets
Competitive landscape
For the 7 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Defense Logistics Agency since 2024 (0 filings)
- 0 of their lobbyists list a past Defense Logistics Agency job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 32 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.